This item comprised:
| XLS |
|
|
|
|
|
|
|
|
|
€ million |
current |
non-current |
Dec. 31, 2013 |
current |
non-current |
Dec. 31, 2012 |
|
Other financial liabilities |
578.9 |
2.2 |
581.1 |
520.1 |
2.8 |
522.9 |
|
Liabilities from derivatives (operational) |
1.5 |
0.6 |
2.1 |
12.2 |
2.8 |
15.0 |
|
Financial items |
580.4 |
2.8 |
583.2 |
532.3 |
5.6 |
537.9 |
|
Accruals for personnel expenses |
439.9 |
– |
439.9 |
466.2 |
– |
466.2 |
|
Deferred income |
31.6 |
2.3 |
33.9 |
29.5 |
2.6 |
32.1 |
|
Advance payments received from customers |
16.0 |
– |
16.0 |
10.1 |
0.1 |
10.2 |
|
Liabilities from non-income related taxes |
66.6 |
0.5 |
67.1 |
58.1 |
1.1 |
59.2 |
|
Non-financial items |
554.1 |
2.8 |
556.9 |
563.9 |
3.8 |
567.7 |
|
|
1,134.5 |
5.6 |
1,140.1 |
1,096.2 |
9.4 |
1,105.6 |
As of December 31, 2013, other financial liabilities included liabilities to related companies amounting to € 373.1 million (2012: € 295.4 million). These are profit entitlements of E. Merck KG. Moreover, this item contained liabilities to investments amounting to € 1.6 million (2012: € 3.6 million), interest accruals of € 83.3 million (2012: € 93.0 million) as well as payroll liabilities of € 63.6 million (2012: € 64.8 million). The remaining amount of € 59.5 million (2012: € 66.1 million) recorded under other financial liabilities included among other things liabilities to insurers as well as contractually agreed payment obligations vis-à-vis other companies.
back
